New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 25, 2013
11:45 EDTSCLNSciClone downgraded earlier to Hold from Buy at Aegis
Aegis downgraded SciClone citing uncertainty regarding the accounting restatement.
News For SCLN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 4, 2016
18:09 EDTSCLNSciClone to consider strategic alternatives, pay $12.8M in SEC settlement
SciClone Pharmaceuticals announced it has entered into a settlement agreement with the Securities and Exchange Commission fully resolving the SEC's investigation into possible violations of the Foreign Corrupt Practices Act. Under the terms of the settlement agreement, SciClone has agreed to pay a total of $12.8M, including disgorgement, pre-judgment interest and a penalty. The payment is "in line" with the charges the company previously recorded and disclosed in August, SciClone noted. In addition, the company announced that its board of directors has initiated a process to identify, examine and consider a range of strategic alternatives available to SciClone with a view to enhancing stockholder value. SciClone has engaged Lazard as its financial advisor to assist the board in evaluating strategic alternatives.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use